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Ankylosing spondylitis (AS): form of arthritis characterized by 
chronic inflammation of the axial skeletal system that causes 
back pain and loss of mobility with strong potential for slow, 
eventual spinal fusion1
• Affects 0.2-0.5% of the United States population 
• No known cure, yet greater than 60 genetic components are 
involved1
HLA-B27: genetic component highly correlated with AS. 
Presence creates inflammatory response at bony attachment 
sites of tendons, ligaments, and joint capsules.2
Presentation can vary widely and may include:
• Intermittent and/or significant back pain and stiffness across 
multiple body segments for long periods of time3
• Peripheral joint involvement
• Chronic inflammatory-related comorbidities4
Purpose: Describe a comprehensive approach for physical 
therapy (PT) management of AS to assist clinical decision 
reasoning and clinical decision making and enhance care 
management in this patient population.
Background Timeline
Hallmark feature of AS: sacroiliac (SI) joint involvement3,5
Patient Presentation
• 27-year old female patient services representative referred to 
outpatient therapy
• MRI confirmed medical diagnosis of AS
• Limited active range of motion (AROM): thoraco-lumbar flexion 
and extension, lumbar lateral flexion and rotation (pain with all)
• Limited strength: hip (all planes, pain), plantarflexors
• Neural assessment: parasthesia to left foot, occasionally to 
right knee
• Activities of daily living: independent, modified or limited 
activity when pain significantly increased
• Relieving factors: minimal relief with shifting positions, 
prescribed medication 
• Goals: long term preservation of independent functional 
mobility, return to recreational activities, minimize need for 
pain medication
Interventions
Home Exercise Program
Hamstring stretch
Lumbar rotations
Bridge with resisted 
abduction
Resisted clam shells
Discussion
• Greatest improvement reported after initiation of Cosentyx and 
Remicade, immunosuppressant drugs utilized to decrease 
systemic inflammation7,8
• Soft tissue mobilization combined with interferential current 
therapy seemed to provide greatest pain relief during PT 
• Goals seemed to provide little insight quantifying patient 
progress and condition
Limitations: limited evidence available regarding PT 
management of AS, publication of this case report prior to 
patient discharge from PT
Future research opportunities: clinical practice guideline, 
treatment guidelines for active vs. non-active AS
Take home point: This case demonstrated the evolving and 
ever-changing nature of AS. Collaborative care, pharmaceutical 
intervention, and patient-centered, symptom-focused 
intervention seemed to provide greatest benefit for this patient.
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Outcomes
Initial         Week 7   Week 13
Lumbar  Flexion: 10cmb*   11.5cm    WNLc
AROMa Extension: 4cm*  4.5cm*    WNL
Left SBd: 14cm*  14cm       14cm
Right SB: 7cm*   13cm*     14cm
SLRe Left: 35°  50°  60°
Right: 36°  48°  72°
Legend: a: AROM – active range of motion, b: cm – centimeters, c: WNL – within normal limits, 
d: SB – sidebend, e: SLR – straight leg raise, (*) denotes pain
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